Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hannah R Palmer

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Expert Review of Anti-Infective Therapy|December 9, 2009
49th ICAAC annual meeting: optimization of anti-infective use in the clinical settingRosa F Yeh, Rupali Jain, Hannah R Palmer
Antimicrobial Agents and Chemotherapy|November 19, 2014
In vitro ceftriaxone susceptibility in methicillin-susceptible Staphylococcus aureusKady Phe, Dorothy Dao, Hannah R Palmer, et al.
Antimicrobial Agents and Chemotherapy|August 20, 2014
Validation of a model to predict the risk of nephrotoxicity in patients receiving colistinKady Phe, Michael L Johnson, Hannah R Palmer, et al.
Pharmacotherapy|March 7, 2012
A real-world evaluation of oral vancomycin for severe Clostridium difficile infection: implications for antibiotic stewardship programsFrank Le, Vaneet Arora, Dhara N Shah, et al.
The Annals of Pharmacotherapy|July 6, 2012
Correlation of hospital carbapenem consumption and resistance trends in selected gram-negative bacteriaVincent H Tam, Elizabeth B Hirsch, Todd M Lasco, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 21, 2015
Oral Bacitracin: A Consideration for Suppression of Intestinal Vancomycin-Resistant Enterococci (VRE) and for VRE Bacteremia From an Apparent Gastrointestinal Tract SourceTruc T Tran, Hannah R Palmer, Marion R Weimar, et al.
Antimicrobial Agents and Chemotherapy|March 14, 2012
Impact of prior inappropriate fluconazole dosing on isolation of fluconazole-nonsusceptible Candida species in hospitalized patients with candidemiaDhara N Shah, Raymond Yau, Todd M Lasco, et al.
The Annals of Pharmacotherapy|April 2, 2014
Clinical practice patterns in hospitalized patients at risk for invasive candidiasis: role of antifungal stewardship programs in an era of rapid diagnosticsSamuel L Aitken, Nicholas D Beyda, Dhara N Shah, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|July 24, 2010
Significant publications on infectious diseases pharmacotherapy in 2009Hannah R Palmer, Jessica M Cottreau, Kevin W Garey, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 22, 2012
Evaluation of a daptomycin dose-optimization protocolTruc T Tran, Hannah R Palmer, Jaye Weston, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Expert Review of Anti-Infective Therapy|December 9, 2009
49th ICAAC annual meeting: optimization of anti-infective use in the clinical settingRosa F Yeh, Rupali Jain, Hannah R Palmer
Antimicrobial Agents and Chemotherapy|November 19, 2014
In vitro ceftriaxone susceptibility in methicillin-susceptible Staphylococcus aureusKady Phe, Dorothy Dao, Hannah R Palmer, et al.
Antimicrobial Agents and Chemotherapy|August 20, 2014
Validation of a model to predict the risk of nephrotoxicity in patients receiving colistinKady Phe, Michael L Johnson, Hannah R Palmer, et al.
Pharmacotherapy|March 7, 2012
A real-world evaluation of oral vancomycin for severe Clostridium difficile infection: implications for antibiotic stewardship programsFrank Le, Vaneet Arora, Dhara N Shah, et al.
The Annals of Pharmacotherapy|July 6, 2012
Correlation of hospital carbapenem consumption and resistance trends in selected gram-negative bacteriaVincent H Tam, Elizabeth B Hirsch, Todd M Lasco, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 21, 2015
Oral Bacitracin: A Consideration for Suppression of Intestinal Vancomycin-Resistant Enterococci (VRE) and for VRE Bacteremia From an Apparent Gastrointestinal Tract SourceTruc T Tran, Hannah R Palmer, Marion R Weimar, et al.
Antimicrobial Agents and Chemotherapy|March 14, 2012
Impact of prior inappropriate fluconazole dosing on isolation of fluconazole-nonsusceptible Candida species in hospitalized patients with candidemiaDhara N Shah, Raymond Yau, Todd M Lasco, et al.
The Annals of Pharmacotherapy|April 2, 2014
Clinical practice patterns in hospitalized patients at risk for invasive candidiasis: role of antifungal stewardship programs in an era of rapid diagnosticsSamuel L Aitken, Nicholas D Beyda, Dhara N Shah, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|July 24, 2010
Significant publications on infectious diseases pharmacotherapy in 2009Hannah R Palmer, Jessica M Cottreau, Kevin W Garey, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 22, 2012
Evaluation of a daptomycin dose-optimization protocolTruc T Tran, Hannah R Palmer, Jaye Weston, et al.
Pageof 2